المؤلفون: Li C; The State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China., Liu B; The State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China., Zhong S; University of Chinese Academy of Sciences, Beijing 100039, China., Wang H; The State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.

المصدر: Oncotarget [Oncotarget] 2016 Jun 28; Vol. 7 (26), pp. 39730-39739.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: DNA Methylation*, Ascorbic Acid/*pharmacology , Benzamides/*pharmacology , Diphenylamine/*analogs & derivatives , MAP Kinase Kinase Kinases/*antagonists & inhibitors , Mouse Embryonic Stem Cells/*drug effects, 5-Methylcytosine/chemistry ; Animals ; Catalysis ; DNA (Cytosine-5-)-Methyltransferases/metabolism ; DNA-Binding Proteins ; Diphenylamine/pharmacology ; Drug Synergism ; Embryonic Stem Cells/cytology ; Gene Silencing ; Germ Cells/cytology ; Mice ; Oxygen/chemistry ; RNA-Binding Proteins ; Transcription Factors/metabolism ; DNA Methyltransferase 3B

المؤلفون: Watson AL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Anderson LK, Greeley AD, Keng VW, Rahrmann EP, Halfond AL, Powell NM, Collins MH, Rizvi T, Moertel CL, Ratner N, Largaespada DA

المصدر: Oncotarget [Oncotarget] 2014 Mar 30; Vol. 5 (6), pp. 1502-14.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Phosphoinositide-3 Kinase Inhibitors*, Benzamides/*pharmacology , Diphenylamine/*analogs & derivatives , Mitogen-Activated Protein Kinases/*antagonists & inhibitors , Neurilemmoma/*prevention & control , Proto-Oncogene Proteins c-akt/*antagonists & inhibitors , Sirolimus/*analogs & derivatives , TOR Serine-Threonine Kinases/*antagonists & inhibitors, Animals ; Apoptosis/drug effects ; Blotting, Western ; Cell Proliferation/drug effects ; Cells, Cultured ; Diphenylamine/pharmacology ; Disease Models, Animal ; Drug Synergism ; Everolimus ; Fluorescent Antibody Technique ; Humans ; Immunoenzyme Techniques ; Immunosuppressive Agents/pharmacology ; Mice ; Mice, Transgenic ; Mitogen-Activated Protein Kinases/metabolism ; Neoplasm Grading ; Neurilemmoma/genetics ; Neurilemmoma/pathology ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Schwann Cells/drug effects ; Schwann Cells/metabolism ; Schwann Cells/pathology ; Signal Transduction/drug effects ; Sirolimus/pharmacology ; TOR Serine-Threonine Kinases/metabolism

المؤلفون: Caenepeel S; Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA, USA., Cooke K; Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA, USA., Wadsworth S; Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA, USA., Huang G; Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA, USA., Robert L; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA., Moreno BH; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA., Parisi G; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA., Cajulis E; Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA, USA., Kendall R; Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA, USA., Beltran P; Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA, USA., Ribas A; Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA., Coxon A; Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA, USA., Hughes PE; Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA, USA.

المصدر: Oncotarget [Oncotarget] 2017 Mar 14; Vol. 8 (11), pp. 17795-17809.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Adaptor Proteins, Signal Transducing/*metabolism , Antineoplastic Agents/*pharmacology , Hepatocyte Growth Factor/*pharmacology , MAP Kinase Signaling System/*drug effects , Melanoma/*pathology , Protein Kinase Inhibitors/*pharmacology , Proto-Oncogene Proteins B-raf/*antagonists & inhibitors , Proto-Oncogene Proteins c-met/*antagonists & inhibitors, Animals ; Apoptosis/drug effects ; Benzamides/pharmacology ; Cell Line, Tumor ; Dipeptides/pharmacology ; Diphenylamine/analogs & derivatives ; Diphenylamine/pharmacology ; Drug Resistance, Neoplasm ; Female ; Humans ; Indoles/pharmacology ; Melanoma/genetics ; Mice ; Mice, Nude ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins c-met/metabolism ; Pyridones/pharmacology ; Sulfonamides/pharmacology ; Triazoles/pharmacology ; Vemurafenib ; Xenograft Model Antitumor Assays

المؤلفون: Manzini C; IRCCS Istituto Giannina Gaslini, Genoa, Italy., Venè R; Oncologia Molecolare e Angiogenesi, IRCCS AOU San Martino-IST, Genoa, Italy., Cossu I; IRCCS Istituto Giannina Gaslini, Genoa, Italy., Gualco M; Anatomia Patologica, IRCCS AOU San Martino-IST, Genoa, Italy., Zupo S; Diagnostica Molecolare, IRCCS AOU San Martino-IST, Genoa, Italy., Dono M; Diagnostica Molecolare, IRCCS AOU San Martino-IST, Genoa, Italy., Spagnolo F; Oncologia Medica 2, IRCCS AOU San Martino-IST, Genoa, Italy., Queirolo P; Oncologia Medica 2, IRCCS AOU San Martino-IST, Genoa, Italy., Moretta L; Department of Experimental Medicine, University of Genoa, Genoa, Italy., Mingari MC; Immunologia, IRCCS AOU San Martino-IST, Genoa, Italy.; Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy., Pietra G; Immunologia, IRCCS AOU San Martino-IST, Genoa, Italy.; Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.

المصدر: Oncotarget [Oncotarget] 2016 Sep 20; Vol. 7 (38), pp. 60858-60871.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Acrylonitrile/*analogs & derivatives , Aniline Compounds/*pharmacology , Interleukin-15/*metabolism , Interleukin-2/*metabolism , Killer Cells, Natural/*drug effects, Acrylonitrile/pharmacology ; Antineoplastic Agents/pharmacology ; Apoptosis ; Benzamides/pharmacology ; Cell Line, Tumor ; Cell Proliferation ; Cell Survival/drug effects ; Diphenylamine/analogs & derivatives ; Diphenylamine/pharmacology ; Down-Regulation/drug effects ; Flow Cytometry ; Humans ; Immunotherapy ; Indoles/pharmacology ; Killer Cells, Natural/metabolism ; Melanoma/drug therapy ; Melanoma/metabolism ; Neoplasm Recurrence, Local/drug therapy ; Oncogenes ; Proto-Oncogene Proteins B-raf/metabolism ; Signal Transduction/drug effects ; Skin Neoplasms/metabolism ; Sulfonamides/pharmacology ; Vemurafenib

المؤلفون: Kendall JJ; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45229, USA., Chaney KE; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45229, USA., Patel AV; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45229, USA., Rizvi TA; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45229, USA., Largaespada DA; Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., Ratner N; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45229, USA.

المصدر: Oncotarget [Oncotarget] 2016 Aug 16; Vol. 7 (33), pp. 53191-53203.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Apoptosis/*drug effects , Casein Kinase II/*antagonists & inhibitors , Naphthyridines/*pharmacology , Nerve Sheath Neoplasms/*drug therapy , beta Catenin/*metabolism, Animals ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Apoptosis/genetics ; Benzamides/administration & dosage ; Benzamides/pharmacology ; Casein Kinase II/genetics ; Casein Kinase II/metabolism ; Cell Cycle Checkpoints/drug effects ; Cell Cycle Checkpoints/genetics ; Cell Line, Tumor ; Cell Survival/drug effects ; Cell Survival/genetics ; Diphenylamine/administration & dosage ; Diphenylamine/analogs & derivatives ; Diphenylamine/pharmacology ; Drug Synergism ; Female ; Humans ; Mice, Nude ; Naphthyridines/administration & dosage ; Nerve Sheath Neoplasms/genetics ; Nerve Sheath Neoplasms/metabolism ; Phenazines ; Proteolysis/drug effects ; RNA Interference ; Xenograft Model Antitumor Assays ; beta Catenin/genetics

المؤلفون: Varin J; EA7331, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Poulain L; Institut Cochin, Département d'Immuno-Hématologie, CNRS UMR8104, INSERM U1016, Paris, France., Hivelin M; Service de Chirurgie Plastique et Reconstructrice, Hôpital Européen Georges Pompidou- AP-HP, Université Paris Descartes, Paris, France., Nusbaum P; Service de Biochimie et de Génétique Moléculaire, Hôpital Cochin, AP-HP, Paris, France., Hubas A; Service de Biochimie et de Génétique Moléculaire, Hôpital Cochin, AP-HP, Paris, France., Laurendeau I; EA7331, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Lantieri L; Service de Chirurgie Plastique et Reconstructrice, Hôpital Européen Georges Pompidou- AP-HP, Université Paris Descartes, Paris, France., Wolkenstein P; Département de Dermatologie, Centre de Référence des Neurofibromatoses, Hôpital Henri-Mondor, AP-HP , Créteil, France.; EA 4393 LIC, Université Paris Est Créteil (UPEC), Créteil, France., Vidaud M; EA7331, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.; Service de Biochimie et de Génétique Moléculaire, Hôpital Cochin, AP-HP, Paris, France., Pasmant E; EA7331, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.; Service de Biochimie et de Génétique Moléculaire, Hôpital Cochin, AP-HP, Paris, France., Chapuis N; Institut Cochin, Département d'Immuno-Hématologie, CNRS UMR8104, INSERM U1016, Paris, France.; Service d'Hématologie Biologique, Hôpital Cochin, AP-HP, Paris, France., Parfait B; EA7331, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.; Service de Biochimie et de Génétique Moléculaire, Hôpital Cochin, AP-HP, Paris, France.

المصدر: Oncotarget [Oncotarget] 2016 Jun 14; Vol. 7 (24), pp. 35753-35767.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Cell Proliferation/*drug effects , Mechanistic Target of Rapamycin Complex 1/*antagonists & inhibitors , Mechanistic Target of Rapamycin Complex 2/*antagonists & inhibitors , Morpholines/*pharmacology , Nerve Sheath Neoplasms/*drug therapy , Neurofibroma, Plexiform/*drug therapy , Protein Kinase Inhibitors/*pharmacology, Antineoplastic Agents/therapeutic use ; Benzamides/pharmacology ; Cell Cycle Proteins ; Cell Line, Tumor ; Cell Movement/drug effects ; Diphenylamine/analogs & derivatives ; Diphenylamine/pharmacology ; Drug Synergism ; G1 Phase Cell Cycle Checkpoints/drug effects ; Humans ; Inhibitory Concentration 50 ; MAP Kinase Kinase 1/antagonists & inhibitors ; MAP Kinase Kinase 1/metabolism ; MAP Kinase Kinase 2/antagonists & inhibitors ; MAP Kinase Kinase 2/metabolism ; Morpholines/therapeutic use ; Nerve Sheath Neoplasms/etiology ; Nerve Sheath Neoplasms/genetics ; Neurofibroma, Plexiform/etiology ; Neurofibroma, Plexiform/genetics ; Neurofibromatosis 1/complications ; Neurofibromatosis 1/genetics ; Neurofibromin 1/genetics ; Nuclear Proteins/metabolism ; Primary Cell Culture ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-akt/metabolism ; Schwann Cells ; Signal Transduction/drug effects ; Sirolimus/pharmacology ; Sirolimus/therapeutic use ; TOR Serine-Threonine Kinases/antagonists & inhibitors ; TOR Serine-Threonine Kinases/metabolism ; Transcription Factors/metabolism ; ras Proteins/metabolism

المؤلفون: Kiessling MK; Division of Gastroenterology and Hepatology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.; Division of Oncology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland., Curioni-Fontecedro A; Division of Oncology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland., Samaras P; Division of Oncology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland., Atrott K; Division of Gastroenterology and Hepatology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland., Cosin-Roger J; Department of Pharmacology and CIBERehd, Faculty of Medicine, University of Valencia, Valencia, Spain., Lang S; Division of Gastroenterology and Hepatology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland., Scharl M; Division of Gastroenterology and Hepatology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland., Rogler G; Division of Gastroenterology and Hepatology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.

المصدر: Oncotarget [Oncotarget] 2015 Dec 08; Vol. 6 (39), pp. 42183-96.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Mitogen-Activated Protein Kinase Kinases/*antagonists & inhibitors , Protein Kinase Inhibitors/*pharmacology , Proto-Oncogene Proteins p21(ras)/*antagonists & inhibitors , TOR Serine-Threonine Kinases/*antagonists & inhibitors, Animals ; Apoptosis/drug effects ; Apoptosis/genetics ; Benzamides/pharmacology ; Benzimidazoles/pharmacology ; Blotting, Western ; Cell Line ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Proliferation/genetics ; Cell Transformation, Neoplastic/drug effects ; Cell Transformation, Neoplastic/genetics ; Diphenylamine/analogs & derivatives ; Diphenylamine/pharmacology ; Humans ; Mice, SCID ; Mitogen-Activated Protein Kinase Kinases/metabolism ; Mutation ; Neoplasms/drug therapy ; Neoplasms/genetics ; Neoplasms/metabolism ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; RNA Interference ; Signal Transduction/drug effects ; Signal Transduction/genetics ; TOR Serine-Threonine Kinases/metabolism ; Tumor Burden/drug effects ; Tumor Burden/genetics ; Xenograft Model Antitumor Assays

المؤلفون: Chua KN; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Kong LR; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Sim WJ; Institute of Molecular and Cell Biology, A*STAR, Singapore., Ng HC; Institute of Molecular and Cell Biology, A*STAR, Singapore., Ong WR; National Cancer Centre, Singapore., Thiery JP; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Institute of Molecular and Cell Biology, A*STAR, Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Huynh H; National Cancer Centre, Singapore., Goh BC; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Department of Hematology-Oncology, National University Hospital, Singapore.; National University Cancer Institute, Singapore.

المصدر: Oncotarget [Oncotarget] 2015 Oct 06; Vol. 6 (30), pp. 29991-30005.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung/*drug therapy , Cell Proliferation/*drug effects , Epithelial-Mesenchymal Transition/*drug effects , Lung Neoplasms/*drug therapy , MAP Kinase Kinase 1/*antagonists & inhibitors , Protein Kinase Inhibitors/*pharmacology , src-Family Kinases/*antagonists & inhibitors, Animals ; Benzamides/pharmacology ; Benzodioxoles/pharmacology ; Cadherins/metabolism ; Carcinoma, Non-Small-Cell Lung/enzymology ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Adhesion/drug effects ; Cell Cycle/drug effects ; Cell Movement/drug effects ; Diphenylamine/analogs & derivatives ; Diphenylamine/pharmacology ; Dose-Response Relationship, Drug ; Drug Synergism ; Female ; Humans ; Immunoblotting ; Lung Neoplasms/enzymology ; Lung Neoplasms/pathology ; MAP Kinase Kinase 1/metabolism ; Mice, Inbred BALB C ; Mice, Nude ; Microscopy, Confocal ; Quinazolines/pharmacology ; Tumor Burden/drug effects ; Xenograft Model Antitumor Assays ; src-Family Kinases/metabolism

المؤلفون: Yoshida T; Pharmaceutical Frontier Research Laboratories, Central Pharmaceutical Institute, Japan Tobacco, Kanazawa-ku, Yokohama, Kanagawa, Japan., Kakegawa J, Yamaguchi T, Hantani Y, Okajima N, Sakai T, Watanabe Y, Nakamura M

المصدر: Oncotarget [Oncotarget] 2012 Dec; Vol. 3 (12), pp. 1533-45.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Molecular Targeted Therapy*, Antineoplastic Agents/*pharmacology , MAP Kinase Kinase 1/*antagonists & inhibitors , MAP Kinase Kinase 2/*antagonists & inhibitors , Neoplasms/*enzymology , Protein Kinase Inhibitors/*pharmacology , Pyridones/*pharmacology , Pyrimidinones/*pharmacology, Allosteric Regulation ; Antineoplastic Agents/chemistry ; Benzamides/pharmacology ; Butadienes/pharmacology ; Chromatography, Affinity ; Diphenylamine/analogs & derivatives ; Diphenylamine/pharmacology ; Dose-Response Relationship, Drug ; HEK293 Cells ; HT29 Cells ; Humans ; Kinetics ; MAP Kinase Kinase 1/metabolism ; MAP Kinase Kinase 2/metabolism ; Molecular Structure ; Neoplasms/pathology ; Nitriles/pharmacology ; Phosphorylation ; Protein Binding ; Protein Kinase Inhibitors/chemistry ; Pyridones/chemistry ; Pyrimidinones/chemistry ; Signal Transduction/drug effects

المؤلفون: Christopher L. Moertel, Amanda L. Halfond, Adrienne L. Watson, Eric P. Rahrmann, David A. Largaespada, Leah K. Anderson, Kyle A. Williams, Andrew D. Greeley, Natasha M. Powell, Namrata N. Damle, Vincent W. Keng, Tilat A. Rizvi, Bryant J. Keller, Margaret H. Collins, Samuel J. Finnerty, Nancy Ratner

المصدر: Oncotarget

مصطلحات موضوعية: MAPK/ERK pathway, Blotting, Western, Fluorescent Antibody Technique, Schwann cell, Apoptosis, Mice, Transgenic, Biology, Immunoenzyme Techniques, Mice, Phosphatidylinositol 3-Kinases, Tumor grade, medicine, Animals, Humans, Everolimus, Protein kinase B, Cells, Cultured, PI3K/AKT/mTOR pathway, Cell Proliferation, Phosphoinositide-3 Kinase Inhibitors, Sirolimus, TOR Serine-Threonine Kinases, Diphenylamine, Correction, Drug Synergism, Disease Models, Animal, medicine.anatomical_structure, Oncology, Genetically Engineered Mouse, Benzamides, Cancer research, Schwann Cells, Mitogen-Activated Protein Kinases, Neoplasm Grading, Proto-Oncogene Proteins c-akt, Immunosuppressive Agents, Neurilemmoma, Signal Transduction

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a5acb1d26cd5c31e1f17d31771bf674
https://doi.org/10.18632/oncotarget.27349